What is ESMO-CoCARE
ESMO has launched an international collaborative project, the ESMO-CoCARE Registry, to quickly gather data and information from healthcare professionals about treatment approaches specifically focusing on the impact of SARS-CoV-2 on cancer patients who are suspected or confirmed to have the novel coronavirus disease (COVID19).
Pooling real-world data will make it possible to rapidly accumulate knowledge, which will allow to disseminate information and guidance for patients. Ultimately the project aims to propose approaches to mitigate the risks related to COVID-19 in cancer patients.
The survey is comprised of several parts, including patient demographics, COVID-19 and cancer diagnosis and treatment, and the evolution of both diseases.
ESMO CoCARE Collaborative Papers
- June 2022: COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
- June 2023: COVID-19 in cancer patients: update from the joint analysis of the ESMO CoCARE Collaborative Papers, BSMO, and PSMO international databases
- July 2023: Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology-shared perspectives from international consortia
Research activities leading to publication with the involvement of the ESMO CoCARE Investigators
- Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
- Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
- The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer
- An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Research activities leading to abstract presentation with involvement of the ESMO CoCARE Investigators
Eligibility to participate
The ESMO-CoCARE Registry initiative is currently closed to new participants.
Contact
Steering Committee
- Emanuela Romano, Institut Curie, Paris, France
- Dirk Arnold, University Hamburg, Asklepios Tumorzentrum, AK Altona, Hamburg, Germany
- Luis Castelo-Branco, Algarve University Hospital, Portugal
- Kevin J. Harrington, The Institute of Cancer Research, London, UK
- Olivier Michielin, Lausanne University Hospital, Switzerland
- George Pentheroudakis, ESMO, Switzerland
- Solange Peters, Lausanne University Hospital, Switzerland (ESMO President)
- Jennifer Whisenant Gray*, Vanderbilt University, Nashville, TN, USA
- Toni Choueiri*, Dana-Farber Cancer Institute, Boston, MA, USA
*CCC19 Representative